Therefore, we hypothesised that during the development of cancer, especially during the angiogenic process, the elevation of VEGF by tumour cells functions more than SEMA3A and NRP1 plays greater roles with VEGF than with SEMA3A. The gene discussed is SEMA3A; the disease is neoplasm.